Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.25
Delayed Data
As of 4:14pm ET
 0.00 / 0.00%
Today’s Change
1.19
Today|||52-Week Range
1.75
-10.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues15.2M21.7M22.4M26.8M
 
 
 
 
 
Cost of Goods Sold9.2M11.5M12.1M14.6M
 
 
 
 
 
Depreciation And Amortization908.0K1.1M986.0K1.0M
 
 
 
 
 
 
Operating ExpensesGross Income5.1M9.1M9.3M11.2M
 
 
 
 
 
General Expenses47.2M37.4M45.0M61.7M
 
 
 
 
 
Research And Development35.7M24.3M27.7M43.0M
 
 
 
 
 
Total Operating Expenses57.3M50.0M58.1M77.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-42.1M-28.4M-35.7M-50.5M
 
 
 
 
 
Extraordinary Charge0.00-1.7M0.000.00
 
 
Interest Expense On Debt90.0K54.0K5.0K0.00
 
 
 
 
Other Expenses0.000.000.00-1.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.1M-29.8M-35.4M-50.4M
 
 
 
 
 
Preferred Dividend0.000.00-401.0K-3.7M
 
 
 
Net Income-42.1M-29.8M-35.4M-50.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS83.6M120.4M161.6M182.6M
 
 
 
 
 
Shares To Calculate EPS Diluted83.6M120.4M161.6M182.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.25-$0.22-$0.30
 
 
 
 
 
EPS Diluted-$0.50-$0.25-$0.22-$0.30